Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
ABSTRACT The mycobacterial caseinolytic protease ClpP1P2 is a degradative protease that recently gained interest as a genetically and pharmacologically validated drug target for tuberculosis. The first whole-cell active ClpP1P2 inhibitor, the human proteasome inhibitor bortezomib, is currently under...
Saved in:
Main Authors: | Yoshiyuki Yamada, Thomas Dick |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/bd664c524a7b41c0ab4868df940839d7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Technical data on the inhibition properties of some medicinal plant extracts towards caseinolytic protease proteolytic subunit of Plasmodium knowlesi
by: Raimalynah Abd Razak, et al.
Published: (2021) -
Synthetic Gene-Based Heterologous Expression, Proteolytic, and Structural Characterization of Caseinolytic Protease of Lactobacillus plantarum IIA-1A5
by: M. Yusuf, et al.
Published: (2021) -
Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
by: Wilfried Moreira, et al.
Published: (2015) -
Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease
by: Maroeska J. Burggraaf, et al.
Published: (2019) -
Protease Inhibitor and Metabolic Alteration
by: Cavenaghi,F. M, et al.
Published: (2012)